Georgios Paschos and Garret FitzGerald of the Perelman School of Medicine are quoted about research conducted on mice that indicate that it matters when you eat rather than what you eat.
Perelman School of Medicine
David Casarett of the Perlman School of Medicine is quoted about a study focused on the significance of end-of-life discussions on treatment strategies.
Gerard Schellenberg of the Perelman School of Medicine comments on a study tied to an Alzheimer’s gene.
Penn Study: Targeting Downstream Proteins in Cancer-Causing Pathway Shows Promise in Cell, Animal Model
PHILADELPHIA — The cancer-causing form of the gene Myc alters the metabolism of mitochondria, the cell’s powerhouse, making it dependent on the amino acid glutamine for survival. In fact, 40 percent of all “hard-to-treat” cancers have a mutation in the Myc gene.
Accordingly, depriving cells of glutamine selectively induces programmed cell death in cells overexpressing mutant Myc.
Daniel Polsky of Penn’s Leonard Davis Institute of Health Economics discusses health-care reform.